Sebia
FranceWho owns Sebia?
Sebia is a French MedTech company, currently owned by CVC Capital Partners since 2018. It changed hands in 2018, when Astorg and Montagu Private Equity sold.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
- ·Held by CVC Capital Partners since 2018 (8Y hold).
- ·Best return: 2.4x MOIC by Cinven (2017 exit).
- ·Average hold across 6 realized cycles: 4 years.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
7 ownership periods · co-invest detected · 1 lender on file
Astorg sold Sebia to Montagu Private Equity in 2006 after 5 years.
Astorg exited Sebia in 2010 after 4 years.
Astorg exited Sebia in 2014 after 4 years.
Astorg sold Sebia to CVC Capital Partners / CDPQ / Tethys in 2018 after 4 years.
Cinven sold Sebia to Montagu Private Equity / Astorg Partners in 2017 after 3 years.
Montagu Private Equity sold Sebia to CVC Capital Partners in 2018 after 4 years.
More from CVC Strategic Opportunities Fund I
Other portfolio companies in the same fund.
UKMore CVC Capital Partners portfolio companies
From the same investor, across funds.
Switzerland
USMore PE-backed in MedTech
Comparable medtech deals from other GPs.
GermanyQuestions
Who owns Sebia?
Sebia is currently owned by CVC Capital Partners, through CVC Strategic Opportunities Fund I, since 2018.
When did CVC Capital Partners acquire Sebia?
CVC Capital Partners acquired Sebia in 2018.
Who did Sebia sell to?
Astorg sold Sebia to CVC Capital Partners / CDPQ / Tethys in 2018 (Secondary). Montagu Private Equity sold Sebia to CVC Capital Partners in 2018 (Secondary). Cinven sold Sebia to Montagu Private Equity / Astorg Partners in 2017 (Secondary), 2.4x return.
Who has owned Sebia over time?
Sebia has been through 8 private-equity ownership periods: Astorg · via Astorg II · 2001–2006 · sold to Montagu Private Equity · (Secondary); Astorg · via Astorg III · 2006–2010; Astorg · via Astorg IV · 2010–2014; Astorg · via Astorg V · 2014–2018 · sold to CVC Capital Partners / CDPQ / Tethys · (Secondary); Montagu Private Equity · via Montagu IV · 2014–2018 · sold to CVC Capital Partners · (Secondary); Cinven · via Cinven Fifth Fund · 2014–2017 · sold to Montagu Private Equity / Astorg Partners · (Secondary) · 2.4x; CVC Capital Partners · via CVC Strategic Opportunities Fund I · since 2018; CIC Private Debt · via CM-CIC Debt Fund 3 · 2021–2010.